Tuberculosis of other male genital organs
ICD-10 A18.15 is a billable code used to indicate a diagnosis of tuberculosis of other male genital organs.
Tuberculosis of other male genital organs refers to the infection caused by Mycobacterium tuberculosis affecting areas such as the epididymis, testis, prostate, and seminal vesicles. This condition is often secondary to pulmonary tuberculosis but can also occur as a primary infection. Clinical manifestations may include scrotal swelling, pain, and systemic symptoms such as fever and weight loss. Diagnosis typically involves a combination of clinical evaluation, imaging studies (such as ultrasound), and microbiological tests, including culture and PCR for Mycobacterium tuberculosis. Treatment usually consists of a multi-drug regimen, including isoniazid, rifampicin, ethambutol, and pyrazinamide, administered for a minimum of six months. Monitoring for drug resistance is crucial, as resistance can complicate treatment and prolong the infection. Public health implications are significant, as tuberculosis is a communicable disease, necessitating contact tracing and isolation procedures for active cases to prevent transmission. Regular follow-up is essential to ensure treatment adherence and monitor for potential complications.
Detailed notes on physical examination findings, imaging results, and laboratory tests.
Evaluation of scrotal masses, infertility investigations, and chronic pelvic pain.
Awareness of tuberculosis as a differential diagnosis in male genital conditions.
Comprehensive history of exposure, travel, and previous tuberculosis infections.
Management of patients with known tuberculosis and complications affecting the male genital tract.
Coordination with public health for contact tracing and reporting.
Performed in cases of severe epididymal tuberculosis.
Operative report detailing the procedure and indication.
Urology specialists should document the rationale for surgical intervention.
Common symptoms include scrotal swelling, pain, fever, and systemic symptoms such as weight loss and night sweats. Patients may also experience infertility.
Diagnosis typically involves clinical evaluation, imaging studies (like ultrasound), and microbiological tests such as cultures or PCR for Mycobacterium tuberculosis.
Treatment usually involves a multi-drug regimen including isoniazid, rifampicin, ethambutol, and pyrazinamide for at least six months, with monitoring for drug resistance.
Public health measures include contact tracing, isolation of active cases, and ensuring treatment adherence to prevent transmission.
